113 related articles for article (PubMed ID: 8283839)
41. Epileptogenic actions of xanthines in relation to their affinities for adenosine A1 receptors in CA3 neurons of hippocampal slices (guinea pig).
Moraidis I; Bingmann D
Brain Res; 1994 Mar; 640(1-2):140-5. PubMed ID: 8004443
[TBL] [Abstract][Full Text] [Related]
42. Inhibitory effect of KW-3902, an adenosine A(1) receptor antagonist, on p-aminohippurate transport in OK cells.
Nagai J; Yano I; Habu Y; Katsura T; Hashimoto Y; Inui K
Biochim Biophys Acta; 1999 Jul; 1419(2):164-72. PubMed ID: 10407068
[TBL] [Abstract][Full Text] [Related]
43. Mechanism of inhibitory effect of citalopram on isolated guinea-pig atria in relation to adenosine receptor.
Pousti A; Deemyad T; Malihi G
Hum Psychopharmacol; 2004 Jul; 19(5):347-50. PubMed ID: 15252827
[TBL] [Abstract][Full Text] [Related]
44. A selective adenosine antagonist (8-cyclopentyl-1,3-dipropylxanthine) eliminates both neuromuscular depression and the action of exogenous adenosine by an effect on A1 receptors.
Redman RS; Silinsky EM
Mol Pharmacol; 1993 Oct; 44(4):835-40. PubMed ID: 8232234
[TBL] [Abstract][Full Text] [Related]
45. Selective A2-adenosine receptor agonists do not alter action potential duration, twitch shortening, or cAMP accumulation in guinea pig, rat, or rabbit isolated ventricular myocytes.
Shryock J; Song Y; Wang D; Baker SP; Olsson RA; Belardinelli L
Circ Res; 1993 Jan; 72(1):194-205. PubMed ID: 8380261
[TBL] [Abstract][Full Text] [Related]
46. Adenosine A(2A) receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats.
Koga K; Kurokawa M; Ochi M; Nakamura J; Kuwana Y
Eur J Pharmacol; 2000 Nov; 408(3):249-55. PubMed ID: 11090641
[TBL] [Abstract][Full Text] [Related]
47. A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig.
Snowdy S; Liang HX; Blackburn B; Lum R; Nelson M; Wang L; Pfister J; Sharma BP; Wolff A; Belardinelli L
Br J Pharmacol; 1999 Jan; 126(1):137-46. PubMed ID: 10051130
[TBL] [Abstract][Full Text] [Related]
48. Diuretic effects of KW-3902, a novel adenosine A1-receptor antagonist, in anesthetized dogs.
Yamagata T; Kobayashi T; Kusaka H; Karasawa A
Biol Pharm Bull; 1994 Dec; 17(12):1599-603. PubMed ID: 7735202
[TBL] [Abstract][Full Text] [Related]
49. Diadenosine-5-phosphate exerts A1-receptor-mediated proarrhythmic effects in rabbit atrial myocardium.
Brandts B; Borchard R; Dirkmann D; Wickenbrock I; Sievers B; van Bracht M; Prull MW; Trappe HJ
Br J Pharmacol; 2003 Aug; 139(7):1265-72. PubMed ID: 12890705
[TBL] [Abstract][Full Text] [Related]
50. Comparison of the potency of 8-phenyltheophylline as an antagonist at A1 and A2 adenosine receptors in atria and aorta from the guinea-pig.
Collis MG; Palmer DB; Saville VL
J Pharm Pharmacol; 1985 Apr; 37(4):278-80. PubMed ID: 2860232
[TBL] [Abstract][Full Text] [Related]
51. A novel non-xanthine adenosine A1 receptor antagonist.
Terai T; Kita Y; Kusunoki T; Shimazaki T; Ando T; Horiai H; Akahane A; Shiokawa Y; Yoshida K
Eur J Pharmacol; 1995 Jun; 279(2-3):217-25. PubMed ID: 7556404
[TBL] [Abstract][Full Text] [Related]
52. The selective adenosine A1 receptor antagonist KW-3902 prevents radiocontrast media-induced nephropathy in rats with chronic nitric oxide deficiency.
Yao K; Heyne N; Erley CM; Risler T; Osswald H
Eur J Pharmacol; 2001 Feb; 414(1):99-104. PubMed ID: 11231000
[TBL] [Abstract][Full Text] [Related]
53. Effects of endogenous adenosine and adenosine receptor agonists on hypoxia-induced myocardial stunning in Guinea-pig atria and papillary muscles.
Gardner NM; Yates L; Broadley KJ
J Cardiovasc Pharmacol; 2004 Mar; 43(3):358-68. PubMed ID: 15076219
[TBL] [Abstract][Full Text] [Related]
54. Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts.
Nakaya H; Furusawa Y; Ogura T; Tamagawa M; Uemura H
Br J Pharmacol; 2000 Dec; 131(7):1363-72. PubMed ID: 11090108
[TBL] [Abstract][Full Text] [Related]
55. Effect of Ado A1- and A2-receptor activation on ventricular fibrillation during hypoxia-reoxygenation.
Chi L; Friedrichs GS; Oh JY; Green AL; Lucchesi BR
Am J Physiol; 1994 Oct; 267(4 Pt 2):H1447-54. PubMed ID: 7943390
[TBL] [Abstract][Full Text] [Related]
56. Protective effects of KW-3902, a novel adenosine A1-receptor antagonist, against gentamicin-induced acute renal failure in rats.
Yao K; Kusaka H; Sato K; Karasawa A
Jpn J Pharmacol; 1994 Jun; 65(2):167-70. PubMed ID: 7967229
[TBL] [Abstract][Full Text] [Related]
57. Evidence for a role for both the adenosine A1 and A3 receptors in protection of isolated human atrial muscle against simulated ischaemia.
Carr CS; Hill RJ; Masamune H; Kennedy SP; Knight DR; Tracey WR; Yellon DM
Cardiovasc Res; 1997 Oct; 36(1):52-9. PubMed ID: 9415272
[TBL] [Abstract][Full Text] [Related]
58. Regulation of purinoceptors in guinea pig pulmonary artery: functional evidences.
Szentmiklósi AJ; Ujfalusi A; Cseppentö A; Antal K; Kovács P; Szabó JZ
Acta Physiol Hung; 1996; 84(3):339-41. PubMed ID: 9219631
[TBL] [Abstract][Full Text] [Related]
59. Adenosine analogs inhibit acetylcholine release and cyclic AMP synthesis in the guinea-pig superior cervical ganglion.
Borasio PG; Pavan B; Fabbri E; Ginanni-Corradini F; Arcelli D; Poli A
Neurosci Lett; 1995 Jan; 184(2):97-100. PubMed ID: 7724055
[TBL] [Abstract][Full Text] [Related]
60. Evidence that the positive inotropic effects of the alkylxanthines are not due to adenosine receptor blockade.
Collis MG; Keddie JR; Torr SR
Br J Pharmacol; 1984 Feb; 81(2):401-7. PubMed ID: 6322898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
